Description: Aker BioMarine AS engages in harvesting krill and supplies krill-derived products worldwide. It operates through two segments, Ingredients and Brands. The Ingredients segment is involved in the offshore harvesting and production, logistical operations, and onshore manufacturing and sales of krill-derived products for nutraceutical, pet food, and aquaculture industries. The Brands segment produces and distributes private label vitamins and supplements to retailers. The company provides Superba, a krill oil; QRILL Aqua, an ingredient for formulated feeds; FloraMarine, a plant-based marine source of DHA omega-3 from algae; and QRILL Pet, a functional marine ingredient for pets. It also offers LYSOVETA, a supplement product for brain health; and Understory, a protein peptides product. In addition, it distributes human health and nutrition products, and natural supplements, as well as provides AION, a circular solution provider that recycles plastic products. The company was founded in 2006 and is headquartered in Lysaker, Norway. Aker BioMarine ASA is a subsidiary of Aker ASA.
Home Page: www.akerbiomarine.com
Oksenøyveien 10
Lysaker,
1327
Norway
Phone:
47 24 13 00 00
Officers
| Name | Title |
|---|---|
| Mr. Matts Johansen | Chief Executive Officer |
| Ms. Katrine Mourud Klaveness | Chief Financial Officer |
| Ms. Hege Spaun | Chief Officer People & Communication |
| Mr. Trond Atle Smedsrud | Chief Executive Officer of Emerging Business |
| Ms. Tone Lorentzen | Chief Operating Officer of Human Health Ingredients |
| Mr. Simon Seward | Chief Executive Officer of Human Health Ingredients |
| Mr. Seth French | Chief Executive Officer of Lang Pharma Nutrition Inc |
| Christopher Robin Vinter | Vice President of IR & Corporate Finance |
| Ms. Lise Wiger | Financial Controller |
Exchange: OL
Country: NO : Norway
Currency: Norwegian Krone (kr)
| GIC Sector: | Consumer Staples |
|---|---|
| GIC Group: | Food, Beverage & Tobacco |
| GIC Industry: | Food Products |
| GIC Sub-Industry: | Packaged Foods & Meats |
| Forward PE: | 38.0228 |
|---|---|
| Trailing PE: | 190.9091 |
| Price-to-Book MRQ: | 2.6331 |
| Price-to-Sales TTM: | 16.4999 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 373 |